SCHEMBL6037012

SCHEMBL6037012

O=C(O)c1ccc2c(c1C(=O)O)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.56
HPGD P15428 3/20 0.56
ALOX12 P18054 3/20 0.56
BRCA1 P38398 3/20 0.56
HSD17B10 Q99714 3/20 0.56
CYP2C9 P11712 2/20 0.56
ALOX15 P16050 2/20 0.56
FTO Q9C0B1 10/20 0.55
MAPT P10636 3/20 0.55
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
HTT P42858 2/20 0.55
TDP1 Q9NUW8 2/20 0.55
CYP2C19 P33261 1/20 0.55
RECQL P46063 1/20 0.55
BLM P54132 1/20 0.55
SMAD3 P84022 1/20 0.55
PRMT1 Q99873 1/20 0.55
ACE2 Q9BYF1 1/20 0.55
LMNA P02545 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7907421 0.92 ALDH1A1 (0.53) ALDH1A1HPGDALOX12BRCA1HSD17B10
SCHEMBL2989053 0.89 HPGD (0.53) ALDH1A1HPGDALOX12BRCA1HSD17B10
SCHEMBL6479542 0.88 FTO (0.58) ALDH1A1HPGDALOX12BRCA1HSD17B10
SCHEMBL17515090 0.86 ALDH1A1 (0.55) ALDH1A1HPGDALOX12BRCA1HSD17B10
SCHEMBL6535901 0.86 HPGD (0.55) ALDH1A1HPGDALOX12BRCA1HSD17B10
SCHEMBL20832 0.86 ALDH1A1 (0.60) ALDH1A1HPGDALOX12BRCA1HSD17B10
SCHEMBL29044412 0.85 ALDH1A1 (0.67) ALDH1A1HPGDALOX12BRCA1HSD17B10
SCHEMBL9878722 0.84 ALDH1A1 (0.56) ALDH1A1HPGDALOX12BRCA1HSD17B10
SCHEMBL384698 0.84 FTO (0.54) ALDH1A1HPGDALOX12BRCA1HSD17B10
SCHEMBL25220939 0.83 HPGD (0.52) ALDH1A1HPGDALOX12BRCA1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060025571-A1 Morphogen-induced dendritic growth CURIS, INC. (US) 2006-02-02 US disclosed
US-20050065083-A1 Methods and compositions for the treatment of motor neuron injury and neuropathy STRYKER CORPORATION 2005-03-24 US disclosed
US-6723698-B2 treating ALS (amyotrophic lateral sclerosis), using a morphogen comprising a dimeric protein of given amino acid sequence; treating motor neuron disorders by activation of the Bone Morphogenic Protein (BMP) pathway using Osteogenic protein-1 (OP-1) CURIS, INC. 2004-04-20 US disclosed
US-20020049159-A1 METHODS AND COMPOSITIONS FOR THE TREATMENT OF MOTOR NEURON INJURY AND NEUROPATHY STRYKER CORPORATION 2002-04-25 US disclosed
US-6229024-B1 WATER SOLUBLE TRIBASIC SALT OF MIXTURE OF 5-CARBOXYFLUORESCEIN AND 6-CARBOXYFLUORESCEIN, AND WATER SOLUBLE TETRABASIC SALT OF 5,6 DICARBOXYFLUORESCEIN SCHMUED LAURENCE C (US) 2001-05-08 US disclosed
US-6229024-B1 WATER SOLUBLE TRIBASIC SALT OF MIXTURE OF 5-CARBOXYFLUORESCEIN AND 6-CARBOXYFLUORESCEIN, AND WATER SOLUBLE TETRABASIC SALT OF 5,6 DICARBOXYFLUORESCEIN SCHMUED LAURENCE C (US) 2001-05-08 US disclosed
EP-1027059-A2 ENHANCEMENT OF MORPHOGEN ACTIVITY Curis, Inc. (US) 2000-08-16 EP disclosed
WO-1999021574-A9 ENHANCEMENT OF MORPHOGEN ACTIVITY CREATIVE BIOMOLECULES INC (US) 1999-08-12 WO disclosed
WO-1999021574-A2 ENHANCEMENT OF MORPHOGEN ACTIVITY CREATIVE BIOMOLECULES, INC. (US) 1999-05-06 WO disclosed
EP-0673433-A1 HEPATIC MODEL MERCK & CO. INC. (US) 1995-09-27 EP disclosed
WO-1994012662-A1 HEPATIC MODEL MERCK & CO., INC. (US) 1994-06-09 WO disclosed
EP-0187076-B1 FLUORESCENT COMPOUNDS, (AMINO-4) NAPHTHALIMIDE DERIVATIVES, THEIR USE IN IMMUNOLOGICAL DETERMINATIONS OF FLUORESCENCE POLARIZATION Etablissement Public dit: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1991-09-18 EP disclosed
EP-0187076-A1 Fluorescent compounds, (amino-4) naphthalimide derivatives, their use in immunological determinations of fluorescence polarization Etablissement Public dit: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1986-07-09 EP disclosed
EP-0018731-B1 MACROMOLECULAR GLYCOSIDASE SUBSTRATES SYVA COMPANY (US) 1983-01-12 EP disclosed
US-4268663-A COMPRISING A POLYSACCHARIDE SUPPORT, AN AMINE-CONTAINING SPACER ARM, AND A CHROMOGEN ENZYMATICALLY LABILE-LINKED TO A MONOSACCHARIDE; IMMUNOASSAY SYVA COMPANY (US) 1981-05-19 US disclosed
EP-0018731-A1 Macromolecular glycosidase substrates SYVA COMPANY (US) 1980-11-12 EP disclosed